Changcheng Shi
Biographic Data
| ID | 5679010 |
|---|---|
| NAME | Changcheng Shi |
| GIVEN NAMES | Changcheng |
| FAMILY NAME | Shi |
| SIGNATURE | SHI C |
| AFFILIATIONS | Hangzhou First People's Hospital |
| ORCID | 0000-0002-8879-4794 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Motor learning improvement by matching visual-haptic error modulation to individual skill level and motivation
Motor learning plays a critical role in psychology, sports science, and neurorehabilitation. However, translating its principles into effective rehabilitation strategies remains a significant challenge. This study established a psychologically informed framework based on the Challenge Point Hypothesis to guide the design of personalized visual-haptic feedback in robot-assisted rehabilitation. We proposed the MISLM algorithm, which matches visual-…
Cost-Effectiveness of Posaconazole vs. First-Generation Triazoles for the Prevention of Invasive Fungal Infections Among High-Risk Patients With Hematological Malignancies in China
Background: Posaconazole is confirmed to be more effective for preventing invasive fungal infections (IFIs) than first-generation triazoles (fluconazole and itraconazole), but its economic value has not been comprehensively evaluated in China. This study compared the cost-effectiveness of these two antifungal prophylaxis regimens in hematological-malignancy patients at high risk for IFIs from the Chinese healthcare perspective. Methods: A hybrid …
Expert consensus statement on therapeutic drug monitoring and individualization of linezolid
Linezolid is an oxazolidinone antibacterial drug, and its therapeutic drug monitoring and individualized treatment have been challenged since its approval. With the in-depth clinical research of linezolid, we have changed our attitude toward its therapeutic drug monitoring and our view of individualized treatment. On the basis of summarizing the existing clinical studies, and based on the practical experience of each expert in their respective pr…
No prominent works on this page.
Cost-Effectiveness of Posaconazole vs. First-Generation Triazoles for the Prevention of Invasive Fungal Infections Among High-Risk Patients With Hematological Malignancies in China
Background: Posaconazole is confirmed to be more effective for preventing invasive fungal infections (IFIs) than first-generation triazoles (fluconazole and itraconazole), but its economic value has not been comprehensively evaluated in China. This study compared the cost-effectiveness of these two antifungal prophylaxis regimens in hematological-malignancy patients at high risk for IFIs from the Chinese healthcare perspective. Methods: A hybrid …
Expert consensus statement on therapeutic drug monitoring and individualization of linezolid
Linezolid is an oxazolidinone antibacterial drug, and its therapeutic drug monitoring and individualized treatment have been challenged since its approval. With the in-depth clinical research of linezolid, we have changed our attitude toward its therapeutic drug monitoring and our view of individualized treatment. On the basis of summarizing the existing clinical studies, and based on the practical experience of each expert in their respective pr…
Motor learning improvement by matching visual-haptic error modulation to individual skill level and motivation
Motor learning plays a critical role in psychology, sports science, and neurorehabilitation. However, translating its principles into effective rehabilitation strategies remains a significant challenge. This study established a psychologically informed framework based on the Challenge Point Hypothesis to guide the design of personalized visual-haptic feedback in robot-assisted rehabilitation. We proposed the MISLM algorithm, which matches visual-…
Medicine (2 works) · Antibiotics Pharmacokinetics and Efficacy (1 works) · Antifungal (1 works) · Antifungal resistance and susceptibility (1 works) · Antimicrobial Resistance in Staphylococcus (1 works) · Bacterial Identification and Susceptibility Testing (1 works) · Clinical trial (1 works) · Compassionate Use (1 works) · Cost effectiveness (1 works) · Cost-effectiveness analysis (1 works)